• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Veracyte, Inc. (VCYT)

    -NasdaqGM
    5.05 Down 0.20(3.81%) Jun 24, 4:00PM EDT
    |After Hours : 5.04 Down 0.01 (0.11%) Jun 24, 5:19PM EDT
    Prev Close:5.25
    Open:4.95
    Bid:5.05 x 8400
    Ask:5.08 x 500
    1y Target Est:10.43
    Beta:N/A
    Earnings Date:Aug 11 - Aug 15 (Est.)
    Day's Range:4.86 - 5.15
    52wk Range:4.21 - 12.47
    Volume:154,277
    Avg Vol (3m):68,691
    Market Cap:140.68M
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for VCYT

    Comparison

    Symbol% ChgMkt Cap
    VCYTDown 3.81%140.68M
    LHDown 1.19%13.27B
    DGXDown 2.02%11.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.31
    Quarterly EPS Est (Jun-16) :-0.34
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Veracyte, Inc. operates as a molecular diagnostics company. It develops and delivers molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patien... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback